BioSpace News Archive

In order to reduce the spread of infection and to comply with regulations and general guidelines issued by the authorities, the Extraordinary General Meeting will, in accordance with temporary legislation, be held only be advance voting.

Dewpoint Therapeutics, the biomolecular condensates company, announced it has raised $77 million in a Series B financing.

Cigna conducts the largest U.S. survey of resilience,i assessing the ability of students and working adults to recover from challenges

Saranas, Inc., developer of the Early Bird® Bleed Monitoring System designed for early detection of internal bleed complications during endovascular procedures, has been awarded a group purchasing agreement with Premier Inc., as part of Premier’s Technology Breakthroughs program.

The program’s unique remote services have supported more than 260 people with ALS throughout the COVID-19 pandemic. NEW ORLEANS & BOSTON--( BUSINESS WIRE )-- Team Gleason, a leading foundation for ALS patient support, is collaborating with Boston Children’s Hospital’s ALS Augmentative Communication Program, which provides expert guidance and support for proactive voice preservation through voice banking, BCH Message Banking™ Protocol and “doub

Aptorum Group Limited announced its launch of Aptorum Innovations - an infectious disease liquid biopsy diagnostics subsidiary and its newly established exclusive in-licensing arrangements with Accelerate Technologies Pte Ltd

Caris’ collaborative network focused on expanding the application of precision medicine in oncology welcomes New England’s largest medical oncology group

The net proceeds from the Offering are approximately €6.2 billion, after deducting underwriting discounts and commissions and estimated expenses related to the Offering payable by Medtronic Luxco.

Clinical Laserthermia Systems Americas, Inc., a subsidiary of CLS AB in Lund, Sweden, announced it will be participating in the upcoming FOCAL2020 Virtual Conference titled, ”Frontiers in Oncologic Prostate Care and Ablative Local Therapy ” being held this October 3-4, 2020.

In recent years, there is remarkable increase in the number of patients living with various health conditions such as anemia, hemophilia, pulmonary embolism, thrombolysis, liver diseases, and deep vein thrombosis.